Two Studies Point to the Quality of Neoantigens in Determining Long-Term Cancer Survival
The quality, not quantity, of tumor neoantigens may best predict a patient’s response to cancer immunotherapy and his or her chance of long-term survival. That finding was based on two groundbreaking studies co-authored by Benjamin Greenbaum, PhD,...
FREEDOM Follow-On Study Confirms Therapy for Patients With Diabetes and Heart Disease
A long-term international study led by researchers at Mount Sinai Heart is helping to establish an optimal standard of care for patients with diabetes and advanced multivessel coronary artery disease—a group at high risk for heart attack and stroke. The...
SinaInnovations Celebrates Past and Looks to Future
Scientists whose revolutionary treatments have cured millions of people with hepatitis C and restored sight to patients with a rare form of blindness were among keynote speakers at the seventh annual SinaInnovations conference, held in Stern Auditorium...
Fourth Annual Mount Sinai Innovation Awards
Individuals and teams from the Mount Sinai Health System were honored for significant advances in research, technology, medicine, and health care at the fourth annual Mount Sinai Innovation Awards ceremony, which was held Monday, October 22, in conjunction...
Health Hackathon Finds Technology-Based Solutions
Mount Sinai hosted its third annual Health Hackathon, an exciting health care innovation competition that ran from Friday, October 19, through Sunday, October 21. Participants included students from the Icahn School of Medicine at Mount Sinai...
Research at the Icahn School of Medicine at Mount Sinai Included in List of Most Influential in 2018
Two publications from researchers at the Icahn School of Medicine at Mount Sinai have been included in an annual listing of the most influential research publications. The two publications were included in the annual Altmetric Top 100, which...
$43 Million Grant for Study of Environmental Effects on Children’s Health
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $43 million grant from the National Institutes of Health (NIH) to continue their work in a sweeping five-year research program called Environmental influences on...
National Cancer Institute Leader Visits Mount Sinai
Aging is one of the greatest risk factors for developing cancer, which is most frequently diagnosed among people aged 65-74. But there are no simple explanations for the “multifaceted” science behind this connection, according to Norman E. Sharpless, MD,...
“New Heights” of Achievement Marked at Convocation
A sense of accomplishment pervaded the 2018 Convocation Ceremony, which honored 13 renowned faculty members and celebrated the 50th anniversary of the Icahn School of Medicine at Mount Sinai. The event, held on Thursday, October 4, marked the...
